These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 8023589

  • 1. Immunological studies in patients with rheumatoid arthritis treated with methotrexate or cyclophosphamide.
    Lacki JK, Schochat T, Sobieska M, Leszczynski P, Wiktorowicz K, Mackiewicz U, Mackiewicz SH, Müller W.
    Z Rheumatol; 1994; 53(2):76-82. PubMed ID: 8023589
    [Abstract] [Full Text] [Related]

  • 2. Acute phase response in rheumatoid arthritis patients treated with immunosuppressive drugs.
    Lacki JK, Klama K, Samborski W, Mackiewicz S, Mackiewicz U, Muller W.
    Mater Med Pol; 1995; 27(2):47-51. PubMed ID: 8935189
    [Abstract] [Full Text] [Related]

  • 3. Do changes in clinical improvement in rheumatoid arthritis patients treated with immunosuppressive drugs reflect the changes in acute phase proteins?
    Lacki JK, Samborski W, Mackiewicz S, Mackiewicz U.
    Ups J Med Sci; 1995; 100(3):233-42. PubMed ID: 8808186
    [Abstract] [Full Text] [Related]

  • 4. Lymphocyte phenotype studies of rheumatoid arthritis patients treated with methotrexate.
    Lacki JK, Mackiewicz SH, Wiktorowicz KE.
    Arch Immunol Ther Exp (Warsz); 1994; 42(4):287-90. PubMed ID: 7487368
    [Abstract] [Full Text] [Related]

  • 5. Contrasting effect of oral and intravenous cyclophosphamide treatment on phenotypes of human peripheral blood lymphocytes.
    Lacki JK, Mackiewicz SH, Wiktorowicz KE.
    Arch Immunol Ther Exp (Warsz); 1994; 42(4):291-4. PubMed ID: 7487369
    [Abstract] [Full Text] [Related]

  • 6. Effects of low dose methotrexate therapy on the concentration and the glycosylation of alpha 1-acid glycoprotein in the serum of patients with rheumatoid arthritis: a longitudinal study.
    De Graaf TW, Van Ommen EC, Van der Stelt ME, Kerstens PJ, Boerbooms AM, Van Dijk W.
    J Rheumatol; 1994 Dec; 21(12):2209-16. PubMed ID: 7699621
    [Abstract] [Full Text] [Related]

  • 7. Microheterogeneity of alpha 1-acid glycoprotein in early and established rheumatoid arthritis.
    Hrycaj P, Sobieska M, Mackiewicz S, Müller W.
    J Rheumatol; 1993 Dec; 20(12):2020-4. PubMed ID: 8014928
    [Abstract] [Full Text] [Related]

  • 8. In active chronic rheumatoid arthritis, dipeptidyl peptidase IV density is increased on monocytes and CD4(+) T lymphocytes.
    Ellingsen T, Hornung N, Møller BK, Hjelm-Poulsen J, Stengaard-Pedersen K.
    Scand J Immunol; 2007 Oct; 66(4):451-7. PubMed ID: 17850590
    [Abstract] [Full Text] [Related]

  • 9. Influence of longterm therapy with methotrexate and low dose corticosteroids on type 1 and type 2 cytokine production in CD4+ and CD8+ T lymphocytes of patients with rheumatoid arthritis.
    Schuerwegh AJ, van Offel JF, Bridts CH, Stevens WJ, De Clerck LS.
    J Rheumatol; 2001 Aug; 28(8):1793-9. PubMed ID: 11508581
    [Abstract] [Full Text] [Related]

  • 10. Interleukin 10 inhibits interleukin 6 production and acute phase response in rheumatoid arthritis.
    Lacki JK, Klama K, Porawska W, Mackiewicz SH, Müller W, Wiktorowicz K.
    Arch Immunol Ther Exp (Warsz); 1995 Aug; 43(1):11-4. PubMed ID: 8744678
    [Abstract] [Full Text] [Related]

  • 11. [Determination of lymphocyte subpopulations and their activation status in patients with rheumatoid arthritis treated with plasma exchange and pulse therapy].
    Sauer H, Häntzschel H, Seidel W.
    Z Gesamte Inn Med; 1991 Dec; 46(18):677-82. PubMed ID: 1796618
    [Abstract] [Full Text] [Related]

  • 12. [Basic therapy of rheumatoid arthritis. Comparison of methotrexate and sulfasalazine].
    Keitel W, Keitel R, Pap T.
    Z Gesamte Inn Med; 1993 Oct; 48(10):480-3. PubMed ID: 7903012
    [Abstract] [Full Text] [Related]

  • 13. Comparison of two schedules for administering oral low-dose methotrexate (weekly versus every-other-week) in patients with rheumatoid arthritis in remission: a twenty-four week, single blind, randomized study.
    Luis M, Pacheco-Tena C, Cazarín-Barrientos J, Lino-Pérez L, Goycochea MV, Vazquez-Mellado J, Burgos-Vargas R.
    Arthritis Rheum; 1999 Oct; 42(10):2160-5. PubMed ID: 10524688
    [Abstract] [Full Text] [Related]

  • 14. Serum matrix metalloproteinase 3 levels during treatment with sulfasalazine or combination of methotrexate and sulfasalazine in patients with early rheumatoid arthritis.
    Posthumus MD, Limburg PC, Westra J, van Leeuwen MA, van Rijswijk MH.
    J Rheumatol; 2002 May; 29(5):883-9. PubMed ID: 12022344
    [Abstract] [Full Text] [Related]

  • 15. Histologic changes in rheumatoid synovitis induced by naproxen and methotrexate.
    Balsa A, Gamallo C, Martín-Mola E, Gijón-Baños J.
    J Rheumatol; 1993 Sep; 20(9):1472-7. PubMed ID: 8164201
    [Abstract] [Full Text] [Related]

  • 16. Methotrexate: clinical and immunological effects in refractory rheumatoid arthritis.
    Singh Y, Sharma M, Singh RR, Kumar A, Malaviya R, Malaviya AN.
    J Assoc Physicians India; 1992 Oct; 40(10):658-61. PubMed ID: 1307351
    [Abstract] [Full Text] [Related]

  • 17. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis.
    Maini RN, Breedveld FC, Kalden JR, Smolen JS, Davis D, Macfarlane JD, Antoni C, Leeb B, Elliott MJ, Woody JN, Schaible TF, Feldmann M.
    Arthritis Rheum; 1998 Sep; 41(9):1552-63. PubMed ID: 9751087
    [Abstract] [Full Text] [Related]

  • 18. Short term effects of low dose methotrexate on the acute phase reaction in patients with rheumatoid arthritis.
    Segal R, Caspi D, Tishler M, Wigler I, Yaron M.
    J Rheumatol; 1989 Jul; 16(7):914-7. PubMed ID: 2504917
    [Abstract] [Full Text] [Related]

  • 19. Effect of low dose methotrexate on markers of bone metabolism in patients with rheumatoid arthritis.
    El Miedany YM, Abubakr IH, El Baddini M.
    J Rheumatol; 1998 Nov; 25(11):2083-7. PubMed ID: 9818648
    [Abstract] [Full Text] [Related]

  • 20. Down-regulation of activating Fcgamma receptors on monocytes of patients with rheumatoid arthritis upon methotrexate treatment.
    Wijngaarden S, van Roon JA, van de Winkel JG, Bijlsma JW, Lafeber FP.
    Rheumatology (Oxford); 2005 Jun; 44(6):729-34. PubMed ID: 15757966
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.